Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank86
3Y CAGR+25.8%
5Y CAGR+29.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+25.8%/yr
vs +41.3%/yr prior
5Y CAGR
+29.2%/yr
Recent deceleration
Acceleration
-15.5pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 86.62 | -69.6% |
| 2024 | 285.13 | -73.4% |
| 2023 | 1070.22 | +2359.6% |
| 2022 | 43.51 | -12.6% |
| 2021 | 49.76 | +107.2% |
| 2020 | 24.02 | +5.6% |
| 2019 | 22.74 | +108.2% |
| 2018 | 10.92 | -63.8% |
| 2017 | 30.12 | +560.4% |
| 2016 | 4.56 | - |